Norway· NO-ID_14174BEE-AD2E-4A33-8168-49892C4AA1CE
Ikervis
A ciclosporin product containing ciclosporin, registered in Norway by Santen Oy. The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Ciclosporin is registered in 14 of 19 countries.
Countries holding a registration under ATC S01XA18 (ciclosporin), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Ciclosporin · ATC S01XA18
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Ciclosporin
- Manufacturer
- Santen Oy
- Country
- Norway (NO)
- ATC code
- S01XA18
- ATC class
- Ciclosporin
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 5
2 priced- no_merkevare_idID_14174BEE-AD2E-4A33-8168-49892C4AA1CE
- no_varenummer39980990 x 0.3NOK 2618.6
- no_varenummer39239030 x 0.3NOK 897
- gtin4987084302731
- gtin6419716000572
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ciclosporin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaIKERVISSanten OY, Tampere
- FinlandIkervisSanten Oy
- SwedenIKERVIS 1 mg/ml Ögondroppar, emulsionSanten Oy
- BelgiumIkervis 1 mg/mlSanten
- PolandIkervisSanten Oy
- IcelandIkervisSanten Oy
- SwitzerlandIkervis, 1 mg/ml collyre en émulsion (unidoses)Santen SA
- FranceIKERVIS 1 mg/mL, collyre en émulsionSANTEN OY
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Cequa®, Neoimmun
- Belgium · Neoral-Sandimmun, Sandimmun
- Bulgaria · Сандимун Неорал
- Cyprus · Sandimmun Neoral
- Czechia · Ciclosporin Viatris, Equoral
- Germany · Cequa, Cicloral
- Denmark · Ciqorin, Menelri
- Estonia · Equoral, Sandimmun Neoral
- Spain · Cequa, Ciqorin
- Finland · Cequa, Ciqorin
- France · Cequa, Ciclograft
- United Kingdom (Northern Ireland) · Capimune, Capsorin
- Greece · Imunofar, Sandimmun
- Croatia · Ciklosporin Alkaloid, Equoral
- Hungary · Sandimmun, Sandimmun Neoral
- Ireland · Deximune, Neoral
- Iceland · Ciqorin, Ikervis
- Italy · Cequa, Ciqorin
- Liechtenstein · Ikervis, Verkazia
- Lithuania · Equoral, Sandimmun Neoral
- Luxembourg · Neoral-Sandimmun, Sandimmun
- Latvia · Sandimmun Neoral
- Malta · Deximune, Sandimmun Neoral
- Netherlands · Cequa, Ciclosporin Teva
- Poland · Cyclaid, Equoral
- Portugal · Ciclosporina Flica Germed Farmacêutica, Ciclosporina Generis
- Romania · Cequa, Sandimmun Neoral
- Sweden · Cequa, Ciklosporin Ivax
- Slovenia · Sandimmun, Sandimmun Neoral
- Slovakia · Ciclosporin Viatris, Equoral
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fbc26040-0616-48a8-adec-eca3ca9dd985 GET /v1/drugs/fbc26040-0616-48a8-adec-eca3ca9dd985?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Øyedråper, emulsjon",
"source": "fest",
"status": "A",
"atc_name": "Ciklosporin",
"merkevare_id": "ID_14174BEE-AD2E-4A33-8168-49892C4AA1CE",
"name_form_strength": "Ikervis øyedr, emul 1 mg/ml",
"prescription_group": "C"
}See everything about ciclosporin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.